Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study Investigating the Safety, Tolerability and Efficacy of PP353 in the Treatment of Patients With Chronic Low Back Pain Associated With Vertebral Body Endplate Bone Oedema (Modic 1)

NCT04238676 is registered in ClinicalTrials.gov with Persica Pharmaceuticals Ltd as lead sponsor.

NCT NCT04238676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04238676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study Investigating the Safety, Tolerability and Efficacy of PP353 in the Treatment of Patients With Chronic Low Back Pain Associated With Vertebral Body Endplate Bone Oedema (Modic 1)
Lead sponsor
Persica Pharmaceuticals Ltd
Phase
Phase 1/2
Overall status
Completed
Start date
January 20, 2020
Completion date
December 9, 2024
Enrollment
43 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

chronic low-back pain